CIK 0001094038 · Non-accelerated filer<br>Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880277072
- Phone
- (713) 400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 10-K Report Annual Report
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Director nominations
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change · Other events
- 4 Insider Changes in Ownership
Page 1 of 46 · 904 filings